Delphinus Medical Technologies

Delphinus Medical Technologies, LLC develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.

Type
Private
HQ
Novi, US
Founded
2010
Employees
51 (est)+2%
Delphinus Medical Technologies was founded in 2010 and is headquartered in Novi, US

Delphinus Medical Technologies Locations

Novi, US
Sunnyvale, US

Delphinus Medical Technologies Metrics

Delphinus Medical Technologies Summary

Founding Date

2010

Total Funding

$58.5 M

Latest funding size

$39.5 M

Time since last funding

about 1 year

Investors

Delphinus Medical Technologies's latest funding round of $39.5 M was in September 2015. In total, Delphinus Medical Technologies has raised $58.5 M.

Delphinus Medical Technologies Company Life